Highlights for the quarter ended
- Successful sale the
CommAgility business onDecember 30, 2022 which raised approximately $12.2 million of net proceeds. Results ofCommAgility are presented as discontinued operations. - Net revenues of $6.7 million, an increase of 14.3% compared to the same period last year
- Gross Profit of $4.0 million, or 60.0% of net revenue, compared to
$3.3 million , or 55.5% of revenue in the same period last year - Net income from continuing operations of $256,000, compared to a net loss from continuing operations of
$250,000 for the same period last year - Net income from discontinued operations of $7.6 million, compared to net income from discontinued operations of
$632,000 for the same period last year - Net income of $7.9 million, compared to net income of $382,000 for the same period last year
- Non-GAAP Adjusted EBITDA of
$590,000 , compared to Non-GAAP Adjusted EBITDA loss of$207,000 for the same period last year
Highlights for the year ended
- Successful sales of the Microlab and
CommAgility businesses which together raised$35.3 million of net proceeds. Results of Microlab andCommAgility are presented as discontinued operations. - Results of our remaining segment, Test & Measurement, are presented as continuing operations, and all references in this release represent continuing operations unless otherwise noted.
- Net revenues of $22.4 million, a decrease of 1.4% compared to the same period last year
- Gross Profit of $12.8 million, or 57.4% of net revenue, a decrease of
$132,000 compared to the same period last year - Net loss from continuing operations of $2.5 million, compared to a net loss from continuing operations of
$692,000 for the same period last year - Net income from discontinued operations of $17.0 million, compared to net income from discontinued operations of
$2.2 million for the same period last year - Net income of
$1 4.6 million, compared to net income of$1.5 million for the same period last year - Non-GAAP Adjusted EBITDA of $705,000, compared to Non-GAAP Adjusted EBITDA of
$110,000 for the same period last year - Cash balance of
$20.7 million as ofDecember 31, 2022 , compared to a cash balance of$4.5 million as ofDecember 31, 2021 - Backlog at
December 31, 2022 , of $6.6 million, a$1.3 million , or 24% year-over-year increase
Full Year 2022 Operating Results:
- Net revenues decreased 1.4% from the prior year driven primarily by supply chain delays impacting our ability to ship additional backlog in the fourth quarter of 2022.
- Gross profit margin increased from 57.2% to 57.4%, reflecting our disciplined pricing power and careful management of supply chain constraints and other inflationary pressures.
- Backlog increased
$1.3 million , to$6.6 million , a 24% year-over-year increase. - Operating expenses were
$15.5 million in 2022 compared to$15.2 million in 2021 reflecting increases in stock compensation expense and non-recurring strategic alternatives expenses, offset by expense reductions in various administrative areas. - GAAP net income was
$14.6 million compared to a net income of$1.5 million in the prior year due to gains recognized on the sales of Microlab andCommAgility . - Adjusted EBITDA was
$705,000 compared to$110,000 in the prior year. Non-GAAP adjusted EBITDA is a metric the Company uses to measure our core operations. A reconciliation of non-GAAP adjusted EBITDA to GAAP net loss is provided later in this press release.
Cash Flow and Balance Sheet
- Cash of
$20.7 million atDecember 31, 2022 , held in money market funds and bearing interest income at 3.75%. - Repayment and termination of both the Muzinich term loan and the Bank of America credit facility, resulting in zero debt on the balance sheet at
December 31, 2022 . - Payment of all acquisition related contingent liabilities, resulting in zero earn-out liabilities at
December 31, 2022 .
Contact
Tel: (973) 386-9696
Fax: (973) 386-9191
www.wirelesstelecomgroup.com
Use of Non-GAAP Financial Measures
The Company reports its financial results in accordance with generally accepted accounting principles (“GAAP”). Management believes, however, that certain non‐GAAP financial measures used in managing the Company’s business may provide users of this financial information with additional meaningful comparisons between current results and prior reported results. Certain of the information set forth herein and certain of the information presented by the Company from time to time may constitute non‐GAAP financial measures within the meaning of Regulation G adopted by the
The Company defines Non-GAAP adjusted operating income/(loss) as GAAP operating income/(loss) excluding non-cash amortization expense of purchased intangible assets, non-recurring expenses associated with our strategic initiatives process, non-cash stock compensation expense, restructuring charges and changes in fair value of contingent consideration.
The Company defines Non-GAAP adjusted net income/(loss) from continuing operations as GAAP net income/(loss) from continuing operations excluding non-cash amortization expense of purchased intangible assets, non-recurring expenses associated with our strategic initiatives process, non-cash stock compensation expense, restructuring charges, changes in fair value of contingent consideration and gains or losses on extinguishment of debt.
The Company defines EBITDA as its net earnings before interest, taxes, depreciation and amortization. “Adjusted EBITDA” is EBITDA excluding our stock compensation expense, restructuring charges, non-recurring expenses associated with our strategic alternatives activities, unrealized and realized foreign exchange gains and losses, non-recurring legal fees associated with arbitration, (gain)/loss on change in fair value of contingent consideration, gain/loss on extinguishment of debt and other non-recurring costs. A reconciliation of net income/(loss) to non-GAAP Adjusted EBITDA is included as an attachment to this press release.
The Company views Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted Operating Income/(Loss) and Non-GAAP Adjusted Net Income/(Loss) from Continuing Operations as important indicators of performance, consistent with the manner in which management measures and forecasts the Company’s performance. We believe Non-GAAP measures are important performance metrics because they facilitate the analysis of our results, exclusive of certain non‐cash and non-recurring items, including items which do not directly correlate to our business operations.
The Company believes that Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted Operating Income/(Loss) and Non-GAAP Adjusted Net Income/(Loss) from Continuing Operations metrics provide qualitative insight into our current performance; we use these measures to evaluate our results, the performance of our management team and our management’s entitlement to incentive compensation; and we believe that making this information available to investors enables them to view our performance the way that we view our performance and thereby gain a meaningful understanding of our core operating results, in general, and from period to period.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, such forward-looking statements may be identified by terms such as believe, expect, seek, may, will, intend, project, anticipate, plan, estimate, guidance or similar words. Forward-looking statements include, among others, include our expectations of revenue growth, continued strong gross margins, reductions in operating expenses and positive cash flow from operations. Investors are cautioned that such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results, including, among others, the ongoing impact that the conflict in
About
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME/(LOSS)
(In thousands, except per share amounts)
For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
(unaudited) | ||||||||||||||||
Net revenues | $ | 6,739 | $ | 5,897 | $ | 22,367 | $ | 22,676 | ||||||||
Cost of revenues | 2,716 | 2,623 | 9,534 | 9,711 | ||||||||||||
Gross profit | 4,023 | 3,274 | 12,833 | 12,965 | ||||||||||||
Operating expenses | ||||||||||||||||
Research and development | 419 | 468 | 1,791 | 1,718 | ||||||||||||
Sales and marketing | 1,105 | 1,081 | 4,046 | 4,003 | ||||||||||||
General and administrative | 2,265 | 2,764 | 9,638 | 9,076 | ||||||||||||
Loss on change in contingent consideration | - | (614 | ) | - | 386 | |||||||||||
Total operating expenses | 3,789 | 3,699 | 15,475 | 15,183 | ||||||||||||
Operating income/(loss) | 234 | (425 | ) | (2,642 | ) | (2,218 | ) | |||||||||
(Loss)/gain on extinguishment of debt | - | - | (792 | ) | 2,045 | |||||||||||
Other income/(expense) | 70 | 42 | 374 | 70 | ||||||||||||
Interest income/(expense) | 28 | (196 | ) | (130 | ) | (1,143 | ) | |||||||||
Income/(loss) before taxes | 332 | (579 | ) | (3,190 | ) | (1,246 | ) | |||||||||
Tax provision/(benefit) | 76 | (329 | ) | (731 | ) | (554 | ) | |||||||||
Net income/(loss) from continuing operations | $ | 256 | $ | (250 | ) | $ | (2,459 | ) | $ | (692 | ) | |||||
Net income from discontinued operations, net of taxes | 7,600 | 632 | 17,048 | 2,192 | ||||||||||||
Net income/(loss) | $ | 7,856 | $ | 382 | $ | 14,589 | $ | 1,500 | ||||||||
Other comprehensive income/(loss): | ||||||||||||||||
Foreign currency translation adjustments | (10 | ) | (6 | ) | (771 | ) | (70 | ) | ||||||||
Comprehensive income/(loss) | $ | 7,846 | $ | (376 | ) | $ | 13,818 | $ | 1,430 | |||||||
Income/(loss) per share from continuing operations: | ||||||||||||||||
Basic | $ | 0.01 | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.03 | ) | |||||
Diluted | $ | 0.01 | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.03 | ) | |||||
Income per share from discontinued operations: | ||||||||||||||||
Basic | $ | 0.36 | $ | 0.03 | $ | 0.79 | $ | 0.10 | ||||||||
Diluted | $ | 0.34 | $ | 0.03 | $ | 0.76 | $ | 0.09 | ||||||||
Income/(loss) per share: | ||||||||||||||||
Basic | $ | 0.37 | $ | 0.02 | $ | 0.68 | $ | 0.07 | ||||||||
Diluted | $ | 0.35 | $ | 0.02 | $ | 0.65 | $ | 0.06 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 21,156 | 22,494 | 21,702 | 22,050 | ||||||||||||
Diluted | 22,049 | 24,858 | 22,540 | 24,297 |
CONSOLIDATED BALANCE SHEETS
(In thousands, except number of shares and par value)
CURRENT ASSETS | ||||||||
Cash & cash equivalents | $ | 20,707 | $ | 4,472 | ||||
Accounts receivable - net of reserves of | 4,762 | 2,044 | ||||||
Inventories - net of reserves of | 5,087 | 4,439 | ||||||
Prepaid expenses and other current assets | 1,685 | 394 | ||||||
Current assets of discontinued operations | - | 9,176 | ||||||
TOTAL CURRENT ASSETS | 32,241 | 20,525 | ||||||
PROPERTY PLANT AND EQUIPMENT - NET | 467 | 469 | ||||||
OTHER ASSETS | ||||||||
6,000 | 6,000 | |||||||
Acquired intangible assets, net | 2,588 | 3,161 | ||||||
Deferred income taxes | 2,913 | 2,407 | ||||||
Right of use assets | 579 | 1,146 | ||||||
Other assets | 185 | 284 | ||||||
Non current assets of discontinued operations | - | 10,359 | ||||||
TOTAL OTHER ASSETS | 12,265 | 23,357 | ||||||
TOTAL ASSETS | $ | 44,973 | $ | 44,351 | ||||
CURRENT LIABILITIES | ||||||||
Short term debt | $ | - | $ | 84 | ||||
Accounts payable | 480 | 644 | ||||||
Short term leases | 251 | 585 | ||||||
Accrued expenses and other current liabilities | 2,693 | 5,836 | ||||||
Deferred revenue | 123 | 24 | ||||||
Current liabilities of discontinued operations | - | 4,296 | ||||||
TOTAL CURRENT LIABILITIES | 3,547 | 11,469 | ||||||
LONG TERM LIABILITIES | ||||||||
Long term debt | - | 3,300 | ||||||
Long term leases | 364 | 615 | ||||||
Other long term liabilities | 24 | 52 | ||||||
Non current liabilities of discontinued operations | - | 295 | ||||||
TOTAL LONG TERM LIABILITIES | 388 | 4,262 | ||||||
COMMITMENTS AND CONTINGENCIES | ||||||||
SHAREHOLDERS’ EQUITY | ||||||||
Preferred stock, | - | - | ||||||
Common stock, 36,440,636 and 35,915,636 shares issued, 21,438,571 and 22,666,074 shares outstanding | 365 | 359 | ||||||
Additional paid in capital | 52,764 | 51,555 | ||||||
Retained earnings | 15,143 | 554 | ||||||
(27,234 | ) | (24,619 | ) | |||||
Accumulated other comprehensive income | - | 771 | ||||||
TOTAL SHAREHOLDERS’ EQUITY | 41,038 | 28,620 | ||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | 44,973 | $ | 44,351 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
For the Twelve Months | ||||||||
Ended | ||||||||
2022 | 2021 | |||||||
CASH FLOWS (USED)/PROVIDED BY OPERATING ACTIVITIES | ||||||||
Net income | $ | 14,589 | $ | 1,500 | ||||
Adjustments to reconcile net income to net cash (used)/provided by operating activities: | ||||||||
Depreciation and amortization | 1,397 | 2,152 | ||||||
Loss/(Gain) on extinguishment of debt | 792 | (2,045 | ) | |||||
(Gain) on sale of Microlab and | (22,834 | ) | - | |||||
- | 258 | |||||||
Amortization of debt issuance fees | 55 | 335 | ||||||
Share-based compensation expense | 1,018 | 316 | ||||||
Deferred rent | (30 | ) | (30 | ) | ||||
Deferred income taxes | 2,666 | (26 | ) | |||||
Provision for doubtful accounts | 9 | 78 | ||||||
Inventory reserves | 62 | 141 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable | (3,060 | ) | 150 | |||||
Inventories | (845 | ) | (427 | ) | ||||
Prepaid expenses and other assets | (1,042 | ) | 976 | |||||
Accounts payable | (193 | ) | 770 | |||||
Deferred revenue | (160 | ) | (515 | ) | ||||
Accrued expenses and other liabilities | (2,078 | ) | 925 | |||||
Net cash (used)/provided by operating activities | (9,654 | ) | 4,558 | |||||
CASH FLOWS PROVIDED/(USED) BY INVESTING ACTIVITIES | ||||||||
Capital expenditures | (722 | ) | (524 | ) | ||||
Acquisition of business, net of cash acquired | (250 | ) | (200 | ) | ||||
Divestiture of Microlab, net | 23,069 | - | ||||||
Divestiture of | 12,205 | - | ||||||
Net cash provided/(used) by investing activities | 34,302 | (724 | ) | |||||
CASH FLOWS USED BY FINANCING ACTIVITIES | ||||||||
Term loan borrowings | - | 345 | ||||||
Term loan repayments | (4,415 | ) | (4,212 | ) | ||||
Acquisition of treasury stock | (2,525 | ) | - | |||||
Payment of contingent consideration | (1,388 | ) | (1,052 | ) | ||||
Proceeds from exercise of stock options | 197 | 208 | ||||||
Tax withholding payments for vested equity awards | (90 | ) | (63 | ) | ||||
ATM share sold | - | 563 | ||||||
Net cash (used) by financing activities | (8,221 | ) | (4,211 | ) | ||||
Effect of Exchange Rate Changes on Cash and Cash Equivalents | (192 | ) | (61 | ) | ||||
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS | 16,235 | (438 | ) | |||||
Cash and Cash Equivalents, at Beginning of Period | 4,472 | 4,910 | ||||||
CASH AND CASH EQUIVALENTS, AT END OF PERIOD | $ | 20,707 | $ | 4,472 | ||||
SUPPLEMENTAL INFORMATION: | ||||||||
Cash paid during the period for interest | $ | 122 | $ | 810 | ||||
Cash paid during the period for income taxes | $ | 988 | $ | 187 |
RECONCILIATION OF NON GAAP MEASURES
(In thousands, unaudited)
Three Months Ended | Twelve Months Ended | |||||||||||||||
Unaudited | Unaudited | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net Income/(loss) from continuing operations | $ | 256 | $ | (250 | ) | $ | (2,459 | ) | $ | (692 | ) | |||||
Tax Provision/(Benefit) | 76 | (329 | ) | (731 | ) | (554 | ) | |||||||||
Depreciation and amortization expense | 243 | 237 | 1,037 | 913 | ||||||||||||
Interest (income)/expense | (28 | ) | 196 | 130 | 1,143 | |||||||||||
Non-GAAP EBITDA | 547 | (146 | ) | (2,023 | ) | 810 | ||||||||||
Stock compensation expense | 68 | 15 | 1,018 | 316 | ||||||||||||
Non recurring strategic alternatives expenses | (78 | ) | 539 | 837 | 654 | |||||||||||
Restructuring Costs | 33 | - | 33 | 25 | ||||||||||||
Change in Fair Value of Contingent Consideration | - | (614 | ) | - | 386 | |||||||||||
FX (Gain)/Loss | 20 | (1 | ) | (52 | ) | (40 | ) | |||||||||
Loss/(Gain) on Extinguishment of Debt | - | - | 792 | (2,045 | ) | |||||||||||
Non recurring HR costs | - | - | 100 | - | ||||||||||||
Non Recurring Arbitration Legal Costs | - | - | - | 4 | ||||||||||||
Non-GAAP Adjusted EBITDA | $ | 590 | $ | (207 | ) | $ | 705 | $ | 110 | |||||||
GAAP Operating Income/(Loss), as reported | $ | 234 | $ | (425 | ) | $ | (2,642 | ) | $ | (2,218 | ) | |||||
Adjustments: | ||||||||||||||||
Amortization of acquired intangible assets | 143 | 143 | 573 | 573 | ||||||||||||
Non recurring strategic alternatives expenses | (78 | ) | 539 | 837 | 654 | |||||||||||
Stock Compensation Expense | 68 | 15 | 1,018 | 316 | ||||||||||||
Restructuring costs and contingent consideration | 33 | (614 | ) | 33 | 411 | |||||||||||
Total Adjustments to operating income/(loss) | 166 | 83 | 2,461 | 1,954 | ||||||||||||
Non-GAAP Adjusted Operating Income/(Loss) | $ | 400 | $ | (342 | ) | $ | (181 | ) | $ | (264 | ) | |||||
Net Income/(loss) from continuing operations, as reported | $ | 256 | $ | (250 | ) | $ | (2,459 | ) | $ | (692 | ) | |||||
Adjustments: | ||||||||||||||||
Total pretax adjustments to operating income/(loss) | 166 | 83 | 2,461 | 1,954 | ||||||||||||
Loss/(Gain) on Extinguishment of Debt | - | - | 792 | (2,045 | ) | |||||||||||
Total Adjustments to Net income/(loss) from continuing operations | 166 | 83 | 3,253 | (91 | ) | |||||||||||
Tax effects of adjustments | 38 | 47 | 745 | (40 | ) | |||||||||||
Non-GAAP Adjusted Net Income/(loss) from continuing operations | $ | 384 | $ | (214 | ) | $ | 49 | $ | (743 | ) | ||||||
Income/(Loss) per share from continuing operations: | ||||||||||||||||
Basic EPS, as reported | $ | 0.01 | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.03 | ) | |||||
Diluted EPS, as reported | $ | 0.01 | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.03 | ) | |||||
Non-GAAP Adjusted Basic EPS | $ | 0.02 | $ | (0.01 | ) | $ | 0.00 | $ | (0.03 | ) | ||||||
Non-GAAP Adjusted Diluted EPS | $ | 0.02 | $ | (0.01 | ) | $ | 0.00 | $ | (0.03 | ) | ||||||
Basic Shares | 21,156 | 22,494 | 21,702 | 22,050 | ||||||||||||
Diluted Shares | 22,049 | 24,858 | 22,540 | 24,297 |
Source:
2023 GlobeNewswire, Inc., source